FOGLX
Price
$12.28
Change
-$0.06 (-0.49%)
Updated
Jul 7 closing price
Net Assets
1.11B
RRCTX
Price
$14.52
Change
-$0.06 (-0.41%)
Updated
Jul 7 closing price
Net Assets
15.12B
Interact to see
Advertisement

FOGLX vs RRCTX

Header iconFOGLX vs RRCTX Comparison
Open Charts FOGLX vs RRCTXBanner chart's image
Fidelity Advisor Freedom 2020 K6
Price$12.28
Change-$0.06 (-0.49%)
VolumeN/A
Net Assets1.11B
American Funds 2020 Trgt Date Retire R6
Price$14.52
Change-$0.06 (-0.41%)
VolumeN/A
Net Assets15.12B
FOGLX vs RRCTX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
FOGLX vs. RRCTX commentary
Jul 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FOGLX is a Hold and RRCTX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RRCTX has more cash in the bank: 15.1B vs. FOGLX (1.11B). RRCTX (2.82) and FOGLX (2.76) have matching dividends . FOGLX was incepted earlier than RRCTX: FOGLX (8 years) vs RRCTX (16 years). RRCTX (0.30) is less costly to investors than FOGLX (0.28). FOGLX is a more actively managed with annual turnover of: 17.00 vs. RRCTX (5.00). FOGLX has a lower initial minimum investment than RRCTX: FOGLX (0) vs RRCTX (250). RRCTX annual gain was more profitable for investors over the last year : 8.87 vs. FOGLX (5.45). RRCTX return over 5 years is better than : 22.17 vs. FOGLX (8.05).
FOGLXRRCTXFOGLX / RRCTX
Total Expense Ratio0.280.3093%
Annual Report Gross Expense Ratio0.280.3093%
Fund Existence8 years16 years-
Gain YTD5.1267.87565%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets1.11B15.1B7%
Annual Yield % from dividends2.762.8298%
Returns for 1 year5.458.8761%
Returns for 3 years23.1123.4599%
Returns for 5 years8.0522.1736%
Returns for 10 yearsN/A40.66-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
INBX18.352.02
+12.37%
Inhibrx Biosciences Inc.
XLO0.70N/A
+0.19%
Xilio Therapeutics
HR15.86-0.06
-0.38%
Healthcare Realty Trust
CDNS320.30-6.51
-1.99%
Cadence Design Systems
INDI3.54-0.20
-5.35%
indie Semiconductor